Stocks Resume Heavy Selling; Neurocrine Biosciences, Meta Platforms, NOV Hold Up

from Stock Market Today With IBD · host Investor's Business Daily

The major indexes returned to sharp losses Tuesday, hitting new lows for the market correction, as the 10-year Treasury yield kept rising. Neurocrine Biosciences, Meta Platforms, Nov are holding up relatively well. Learn more about your ad choices. Visit megaphone.fm/adchoices

Episode metadata supplied by the publisher feed · Published Sep 26, 2023

Embed this episode

Attribution link and audio player

NOW PLAYING

Stocks Resume Heavy Selling; Neurocrine Biosciences, Meta Platforms, NOV Hold Up

0:00 17:45

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

Wild WinsDay Wild WinsDay Pump the hump with WILD WINSday 🐪💪: Your 3-minute weekly video boost for leadership, sales, marketing, and business breakthroughs to WIN the day!

Frequently Asked Questions

How long is this episode of Stock Market Today With IBD?

This episode is 17 minutes long.

When was this Stock Market Today With IBD episode published?

This episode was published on September 26, 2023.

Can I download this Stock Market Today With IBD episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!